Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 16.44% on an a

Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 18.64% on an a

Wedbush analyst David Nierengarten reiterates Cogent Biosciences (NASDAQ:COGT) with a Outperform

HC Wainwright & Co. analyst Robert Burns reiterates Cogent Biosciences (NASDAQ:COGT) with a B

NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful re

On September 1, 2026, Cogent Biosciences, Inc. (the "Company") entered into a Commercial Sup

Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 22.44% on an a

Piper Sandler analyst Christopher Raymond maintains Cogent Biosciences (NASDAQ:COGT) with a Overw

Guggenheim analyst Michael Schmidt maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and rais

Up to $400,000,000COMMON STOCKWe have entered into a Sales Agreement with Guggenheim Securities, LLC

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.52) per share which beat the analy

Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 28.96% on an a

FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 20

U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. H

  On Tuesday, 647 companies set new 52-week lows.

Gainers

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company an

  On Wednesday, 807 companies reached new 52-week lows.

  During Tuesday's session, 454 stocks hit new 52-week lows.

    On Monday, 671 companies achieved new lows for the year.

Upgrades